Junwei Wang

机构：Nanjing University of Chinese Medicine, Union Hospital, Chinese Academy of Sciences, Peking University, Jiangsu Second Normal University, Guangzhou Institutes of Biomedicine and Health, Regenerative Medicine Institute, Peking University Third Hospital, Ministry of Education, Huazhong University of Science and Technology, University of Hong Kong · ORCID：0000-0001-7526-325X

发表论文 80 篇 · 总被引 1542 次 · h-index 21

代表论文

• CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer (2024 · Pharmacological Research · 被引 83)
• Anionic covalent organic framework membranes for the removal of per- and polyfluoroalkyl substances with enhanced selectivity (2024 · Journal of Membrane Science · 被引 48)
• Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors (2024 · Journal of Medicinal Chemistry · 被引 31)
• Research progress of active compounds from traditional Chinese medicine in the treatment of stroke (2025 · European Journal of Medicinal Chemistry · 被引 15)
• Large-scale generation of IL-12 secreting macrophages from human pluripotent stem cells for cancer therapy (2024 · Molecular Therapy — Methods & Clinical Development · 被引 12)
• CircCOL5A1 is involved in proliferation, invasion, and inhibition of ferroptosis of colorectal cancer cells via miR‐1287‐5p/SLC7A11 (2024 · Journal of Biochemical and Molecular Toxicology · 被引 10)